Related Experiment Video
Updated: Mar 14, 2026

Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection
Published on: August 20, 2007
Epidemiological features of invasive mold infections among solid organ transplant recipients: PATH Alliance® registry
Shahid Husain1, Fernanda P Silveira2, Nkechi Azie3
1Multi-organ Transplant Program, Infectious Diseases Division, University Health Network, University of Toronto, 11 PMB 138, 585 University Avenue, Toronto, ON, M5G 2N2, Canada.
Abstract:
Epidemiological characteristics of 333 proven and probable invasive mould infections (IMIs) among solid organ transplant recipients (SOTRs) identified between 2004 and 2008 from the Prospective Antifungal Therapy Alliance (PATH) registry are presented. Liver transplant recipients (LTRs) had the lowest median time to IMIs (109 days; interquartile range [IQR] 24-611 days), the highest rate of disseminated disease (n/N = 18/33; 55%), and highest mortality (n/N = 21/33; 64%). Lung transplant recipients had highest median time to IMIs (486 days; IQR 117-1358 days) and lowest mortality (n/N = 31/184; 17%). Complete or partial response at week 12 in patients with invasive aspergillosis (IA) was 67% (n/N = 189/281), and 41% (n/N = 9/22) in mucormycosis patients. In the composite outcome of death or no response to therapy, LTRs had the worst outcome. Higher suspicion of mold infection and institution of appropriate antifungal prophylactic strategies are warranted, especially in high risk LTRs.
Insights
Solid organ transplant recipients (SOTRs) face invasive mould infections (IMIs). Liver transplant recipients (LTRs) experience earlier IMIs, higher disseminated disease rates, and worse outcomes compared to other SOTRs.
Area of Science:
- Infectious Diseases
- Transplantation Medicine
- Mycology
Background:
- Invasive mould infections (IMIs) are a significant concern in solid organ transplant recipients (SOTRs).
- Understanding the epidemiological characteristics of IMIs is crucial for improving patient outcomes.
Purpose of the Study:
- To present the epidemiological characteristics of 333 proven and probable IMIs in SOTRs.
- To compare IMI incidence, disease dissemination, mortality, and treatment response across different SOTR groups.
- To identify risk factors and inform antifungal strategies.
Main Methods:
- Analysis of data from 333 SOTRs with IMIs from the Prospective Antifungal Therapy Alliance (PATH) registry (2004-2008).
- Comparison of epidemiological features, including time to IMI, disseminated disease rates, and mortality, among different transplant types (e.g., liver, lung).
- Evaluation of treatment response rates for invasive aspergillosis and mucormycosis.
Main Results:
- Liver transplant recipients (LTRs) had the shortest median time to IMI (109 days), highest disseminated disease rate (55%), and highest mortality (64%).
- Lung transplant recipients (LTRs) had the longest median time to IMI (486 days) and lowest mortality (17%).
- Treatment response at week 12 was 67% for invasive aspergillosis and 41% for mucormycosis. LTRs showed the worst composite outcome of death or no response.
Conclusions:
- LTRs represent a high-risk group for severe IMIs with poorer prognoses.
- Increased vigilance for mold infections and proactive antifungal prophylaxis are recommended, particularly for LTRs.
- Tailored antifungal strategies based on transplant type and IMI characteristics are warranted.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Kidney Transplant I: Introduction
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Kidney Transplant III: Nursing Management
Fungal Group Zygomycota

